secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2026-05-14T20:10:16+00:00
Accession:  0001837607-26-000043
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma posts corporate presentation targeting $3.5B neurotoxin market
-----------------------------------------------------------------------------

- Corporate presentation made available on IR website, dated May 2026.
- Presentation states AEON aims to disrupt a $3.5B neurotoxin market dominated by a single brand for over 30 years.
- No specific financial results, clinical updates, or guidance changes disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760726000043/0001837607-26-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760726000043/aeon-20260514x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-26-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer